SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 161 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $2,721,000 | -49.1% | 482,500 | 0.0% | 0.16% | -45.5% |
Q2 2015 | $5,351,000 | -29.3% | 482,500 | 0.0% | 0.29% | -49.0% |
Q1 2015 | $7,566,000 | +3.1% | 482,500 | 0.0% | 0.57% | -29.0% |
Q4 2014 | $7,339,000 | +41.0% | 482,500 | 0.0% | 0.80% | +10.2% |
Q3 2014 | $5,204,000 | -29.4% | 482,500 | 0.0% | 0.73% | -27.4% |
Q2 2014 | $7,368,000 | -11.9% | 482,500 | +4.3% | 1.00% | -22.8% |
Q1 2014 | $8,362,000 | +177.1% | 462,500 | +112.8% | 1.30% | +39.6% |
Q4 2013 | $3,018,000 | – | 217,300 | – | 0.93% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |